Naba Alsaha Medical Services Company SJSC 9546.SR · SAR
Health Care · Tadawul · 🇸🇦 Saudi Arabia
22.50
—
Close of 9 Nov 2026, in SAR
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in SAR, from our data supplier.
Revenue
SAR 201.8m
FY2020FY2025
Net income
SAR 27.5m
FY2020FY2025
Free cash flow
−SAR 51.2m
FY2020FY2025
Shareholders' equity
SAR 222.9m
FY2020FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|
| Revenue | SAR 201.8m | SAR 194.3m | SAR 182.4m | SAR 129.7m | SAR 117.7m | SAR 115.7m |
| Gross profit | SAR 66.2m | SAR 62.4m | SAR 73.8m | SAR 51.6m | SAR 46.8m | SAR 45.9m |
| Operating income | SAR 30.8m | SAR 25.2m | SAR 43.0m | SAR 28.3m | SAR 27.0m | SAR 27.6m |
| Net income | SAR 27.5m | SAR 21.8m | SAR 52.4m | SAR 26.9m | SAR 25.8m | SAR 26.7m |
| Diluted earnings per share | 2.62 | 2.07 | 4.99 | 2.56 | 2.46 | 2.54 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|
| Total assets | SAR 385.3m | SAR 324.4m | SAR 276.7m | SAR 170.5m | SAR 158.1m | SAR 145.4m |
| Cash and short-term investments | — | SAR 42.8m | SAR 5.7m | SAR 13.8m | SAR 7.0m | SAR 1.8m |
| Total liabilities | SAR 162.4m | SAR 124.7m | SAR 96.6m | SAR 40.5m | SAR 55.3m | SAR 67.0m |
| Debt | SAR 120.8m | SAR 91.0m | SAR 48.2m | SAR 22.1m | SAR 33.3m | SAR 49.3m |
| Shareholders' equity | SAR 222.9m | SAR 199.7m | SAR 180.1m | SAR 130.0m | SAR 102.9m | SAR 78.4m |
| Shares outstanding | 11m | 11m | 11m | 11m | 11m | 11m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|
| Cash from operations | SAR 26.8m | SAR 35.6m | SAR 29.4m | SAR 35.5m | SAR 30.7m | SAR 6.0m |
| Capital spending | −SAR 78.0m | −SAR 38.4m | −SAR 41.5m | −SAR 11.1m | −SAR 10.4m | −SAR 39.6m |
| Free cash flow | −SAR 51.2m | −SAR 2.8m | −SAR 12.1m | SAR 24.4m | SAR 20.4m | −SAR 33.6m |
| Dividends paid | −SAR 3.1m | — | −SAR 2.1m | −SAR 2.1m | — | −SAR 1.8m |
Latest quarters
By quarter end
| Dec 2025 | Jun 2025 | Dec 2024 | Jun 2024 | Dec 2023 | Jun 2023 | Dec 2022 | Jun 2022 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | SAR 103.7m | SAR 98.1m | SAR 98.0m | SAR 96.3m | SAR 100.5m | SAR 81.8m | SAR 66.8m | SAR 62.9m |
| Gross profit | SAR 34.0m | SAR 32.1m | SAR 30.8m | SAR 31.5m | SAR 38.1m | SAR 33.6m | SAR 24.3m | SAR 27.3m |
| Operating income | SAR 16.6m | SAR 14.2m | SAR 9.8m | SAR 14.7m | SAR 24.3m | SAR 18.7m | SAR 12.7m | SAR 15.6m |
| Net income | SAR 13.3m | SAR 14.2m | SAR 8.7m | SAR 13.0m | SAR 24.6m | SAR 27.8m | SAR 11.5m | SAR 15.4m |
| Diluted earnings per share | 1.27 | 1.35 | 0.83 | 1.24 | 2.34 | 2.64 | 1.10 | 1.47 |
| Cash from operations | — | SAR 17.0m | SAR 16.0m | SAR 18.0m | SAR 16.0m | SAR 12.0m | SAR 21.0m | SAR 13.0m |
| Capital spending | — | −SAR 47.0m | −SAR 17.0m | −SAR 20.0m | −SAR 33.0m | −SAR 5.0m | −SAR 8.0m | −SAR 2.0m |
| Free cash flow | — | −SAR 30.0m | −SAR 1.0m | −SAR 2.0m | −SAR 17.0m | SAR 7.0m | SAR 13.0m | SAR 11.0m |
| Total assets | SAR 385.3m | SAR 339.8m | SAR 324.4m | SAR 285.8m | SAR 276.7m | SAR 227.1m | SAR 170.5m | SAR 167.6m |
| Cash and short-term investments | — | SAR 6.8m | SAR 42.8m | SAR 9.0m | SAR 5.7m | SAR 8.8m | SAR 13.8m | SAR 8.3m |
| Debt | SAR 120.8m | SAR 86.3m | SAR 88.6m | SAR 51.1m | SAR 44.7m | SAR 15.7m | SAR 17.5m | SAR 5.0m |
| Shareholders' equity | SAR 222.9m | SAR 210.7m | SAR 199.7m | SAR 193.1m | SAR 180.1m | SAR 155.7m | SAR 130.0m | SAR 118.3m |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 15.9% | 11.8% | — |
| Operating income | 2.8% | 2.2% | — |
| Net income | 0.7% | 0.6% | — |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Gross margin | 32.5% | 35.9% | 36.8% | — |
| Operating margin | 14.1% | 18.0% | 19.3% | — |
| Net margin | 12.4% | 18.2% | 19.2% | — |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|
| Price to earnings | 9.3 | 19.0 | 6.0 | 5.6 |
| Price to sales | 1.3 | 2.1 | 1.7 | 1.2 |
Dividends and splits
Per share, in the currency the company pays
Paid for 1 years. Last went ex-dividend on 24 Mar 2025.
| FY2025 | FY2023 | |
|---|---|---|
| Paid in the year | 0.15 | 0.10 |
- 3-for-2 split · 20 Nov 2023
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.